Lytenava

bevacizumab · Outlook Therapeutics NL B. V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Lytenava, covering 2026-02-09 to 2026-08-03. Get the full timeline:

Most recent: EMA Authorised: Lytenava (bevacizumab) — Outlook Therapeutics NL B. V.